• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cytokinetics (NQ: CYTK )

    62.82 +1.50 (+2.45%)
    Streaming Delayed Price Updated: 2:13 PM EDT, May 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 482,356
    Open 61.41
    Bid (Size) 62.79 (2)
    Ask (Size) 62.94 (4)
    Prev. Close 61.32
    Today's Range 61.37 - 63.13
    52wk Range 25.98 - 110.25
    Shares Outstanding 95,640,600
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    (CYTK) - Analyzing Cytokinetics's Short Interest
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: April 2024
    With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip. 
    Via InvestorPlace

    Performance

    YTD
    -25.32%
    -25.32%
    1 Month
    -13.97%
    -13.97%
    3 Month
    -20.21%
    -20.21%
    6 Month
    +80.21%
    +80.21%
    1 Year
    +66.32%
    +66.32%

    More News

    Read More
    $100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    2 Incredible Growth Stocks to Buy Right Now
    Via The Motley Fool
    7 Biotech Stocks Ready to Ride the Sector’s Resurgence
    Via InvestorPlace
    Masters In Trading - Saturday, March 16
    Via Talk Markets
    Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
    Via Benzinga
    Unpacking the Latest Options Trading Trends in Cytokinetics
    Via Benzinga
    Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
    Via Benzinga
    7 Biotech Stocks to Buy as Sector Rotation Ramps Up
    Via InvestorPlace
    Super Micro, Deckers To Join S&P 500 Index
    Via Investor's Business Daily
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    Overbought, Overextended - What's The Buzz In S&P 500 Now?
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
    Via Benzinga
    3 Biotech Stocks to Buy for the Next Bull Run: February 2024
    Via InvestorPlace
    Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today
    Via Benzinga
    How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month
    Via Investor's Business Daily
    Banco Santander, Lloyds Banking And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
    Via InvestorPlace
    Biotech Playbook: Small Caps Show Momentum Peaking During
    Via Talk Markets
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
    Via Benzinga
    Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.